What the study found
Peripartum cardiomyopathy, a form of heart failure that occurs at the end of pregnancy or soon after delivery, was uncommon in this West-Norwegian population. The study also found that the patients generally recovered heart function over time.
Why the authors say this matters
The authors conclude that higher pre-pregnancy body mass index and elevated systolic blood pressure are important modifiable cardiovascular risk factors associated with peripartum cardiomyopathy. They also say larger collaborative studies are needed to give a reliable nationwide picture of incidence and outcomes.
What the researchers tested
This single-center case-control study identified 15 cases of peripartum cardiomyopathy at Haukeland University Hospital from 2011 to 2023. The Bergen Birth Registry was used to estimate total births and recruit 30 age-matched healthy controls, and the researchers collected clinical characteristics, echocardiographic data, and outcomes.
What worked and what didn't
The incidence rate was 1 in 4,182 births. Higher pre-pregnancy body mass index and elevated systolic blood pressure were reported as predictors, and pre-eclampsia and primiparity were significantly more common in patients than in controls. Left ventricular ejection fraction increased from 35% at presentation to 58% at 6-month follow-up, and there were no maternal or neonatal deaths; three patients needed intensive care, and none had major cardiovascular events.
What to keep in mind
The study was single-center and included only 15 cases, so the sample was small. The abstract also says that future large collaborative studies are necessary to describe incidence and outcomes nationwide.
- Peripartum cardiomyopathy was identified in 15 cases over 2011 to 2023.
- The incidence rate was 1 in 4,182 births in this West-Norwegian population.
- Higher pre-pregnancy body mass index and higher systolic blood pressure were reported as predictors.
- Pre-eclampsia and primiparity were more common in patients than in controls.
- Mean left ventricular ejection fraction rose from 35% to 58% by 6 months.
- There were no maternal or neonatal deaths, and no major cardiovascular events.